Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
Pavone-Macaluso M, Schröder FH, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R, Smith PH, Suciu S. Pavone-Macaluso M, et al. Among authors: barasolo e. Prog Clin Biol Res. 1989;303:111-6. Prog Clin Biol Res. 1989. PMID: 2528735 Clinical Trial. No abstract available.
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.
Pavone-Macaluso M, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R. Pavone-Macaluso M, et al. Among authors: barasolo e. J Urol. 1986 Sep;136(3):624-31. doi: 10.1016/s0022-5347(17)44996-2. J Urol. 1986. PMID: 2942707 Clinical Trial.
[Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
Pavone-Macaluso M, Martínez-Piñeiro JA, de Voogt H, Lardennois B, Nasta A, Zolfanelli R, Barasolo E, De Pauw M, Suciu S, Sulvester R. Pavone-Macaluso M, et al. Among authors: barasolo e. Arch Esp Urol. 1982 Sep-Oct;35(5):304-11. Arch Esp Urol. 1982. PMID: 6217788 Clinical Trial. Spanish. No abstract available.
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.
Gacci M, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Greco I, Maggi S, Magrini SM, Mirone V, Montironi R, Morgia G, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Russo G, Salonia A, Simonato A, Serni S, Tomasini D, Tubaro A, Zagonel V, Crepaldi G; MIRROR-SIU/LUNA Study Group and the Pros-IT CNR Study Group. Gacci M, et al. World J Urol. 2021 May;39(5):1445-1452. doi: 10.1007/s00345-020-03350-5. Epub 2020 Aug 1. World J Urol. 2021. PMID: 32740803
[Vesico-ureteral reflux in patients with prostatic disease].
Acanfora F, Arena GC, Barasolo E, Aquilini B, Zolfanelli R. Acanfora F, et al. Among authors: barasolo e. Minerva Urol. 1979 Jul-Sep;31(3):149-54. Minerva Urol. 1979. PMID: 91943 Italian. No abstract available.
[Bladder distention in the treatment of inoperable bladder neoplasms].
Ventura M, Zolfanelli R, Conti PG, Barasolo E, Cagna G, Acanfora F, Bossola M. Ventura M, et al. Among authors: barasolo e. J Urol Nephrol (Paris). 1979 Jan-Feb;85(1-2):68-75. J Urol Nephrol (Paris). 1979. PMID: 439200 French. No abstract available.
32 results